CATALAYER NEWS
FDA Alignment to Advance ProstACT Global Phase 3 Trial – Company Announcement - Financial Times
Source: Financial Times · 2026-07-01
Full article text is available in the Catalayer news terminal.
MORE FROM FINANCIAL TIMES
The Vanguard Group, Inc.: Rotork PLC – Company Announcement - Financial Times
2026-07-28
Form 8.3 - The Vanguard Group, Inc.: Schroders PLC – Company Announcement - Financial Times
2026-07-28
Form 8.3 - The Vanguard Group, Inc.: DCC plc – Company Announcement - Financial Times
2026-07-28
Eastman Kodak Company Second-Quarter 2026 Earnings Conference Call - Financial Times
2026-07-28
Laredo Oil Provides Update on International Business Development – Company Announcement - Financial Times
2026-07-28
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets